Search results
Markov Biosciences was founded in 2023 by Adam Green. He founded the company because it appeared no one was taking the scaling hypothesis seriously in the world of biology, despite much lip-service being given to the idea.
Founder at Markov Bio · Experience: Markov Bio · Education: Washington University in St. Louis · Location: San Francisco · 22 connections on LinkedIn.
- 22
- 22
- Markov Bio
Part 4 will explain the scaling hypothesis of biomedical dynamics and why it is correct in the long-run. Part 5 will explain why biocomputational capacity is the primary bottleneck to biomedical progress over the next few decades. We’ll then briefly outline how to build better biocomputers.
Accelerate therapeutics discovery. The combination of simulator and interpretability tools enables researchers to run experiments and analyze their results in silico, accelerating the early-stage research iteration loop.
A sampling of our research in AI and computational biology.
See Markov Biosciences funding rounds, investors, investments, exits and more. Evaluate their financials based on Markov Biosciences's post-money valuation and revenue.
Dec 10, 2015 · About. I am interested in integrating science, management, and policy to better and more efficiently manage and protect natural resources, while considering the multiple interests of all...
- Bureau of Land Management
